Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × trametinib × Clear all

NCT01990196 2025-08-17

Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer

Phase 2 Active not recruiting

Prostatic Neoplasms